Announcements
- Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Lifecore Biomedical Completes Incremental Liquidity Initiatives
- Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
- Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
- Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
- Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
- Lifecore Biomedical Provides Business Update
More ▼
Key statistics
On Friday, Lifecore Biomedical Inc (LDE:DUS) closed at 5.25, 5.42% above its 52-week low of 4.98, set on May 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.20 |
---|---|
High | 5.25 |
Low | 5.15 |
Bid | 5.25 |
Offer | 5.50 |
Previous close | 5.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 30.55m |
Free float | 28.64m |
P/E (TTM) | -- |
Market cap | 178.39m USD |
EPS (TTM) | -2.12 USD |
Data delayed at least 15 minutes, as of May 31 2024 18:31 BST.
More ▼